BDBM213850 6-{[(1r)-1- cyclobutylethyl]amino}- 7-[3-fluoro-4- (trifluoromethyl)benzyl]- 8-[5-methyl-4-(1- methylethyl)pyridin-2- yl]-7h-purine-2- carboxylic acid::US9540377, 1.92

SMILES CC(C)c1cc(ncc1C)-c1nc2nc(nc(N[C@H](C)C3CCC3)c2n1Cc1ccc(c(F)c1)C(F)(F)F)C(O)=O

InChI Key InChIKey=DXTTWABJZFINNX-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 213850   

TargetE3 ubiquitin-protein ligase Mdm2 [17-125](Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 213850BDBM213850(US9540377, 1.92 | 6-{[(1r)-1- cyclobutylethyl]amin...)
Affinity DataIC50: 15.9nMT: 2°CAssay Description:An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2018
Entry Details
US Patent